1. Home
  2. VNRX vs FSI Comparison

VNRX vs FSI Comparison

Compare VNRX & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • FSI
  • Stock Information
  • Founded
  • VNRX N/A
  • FSI 1991
  • Country
  • VNRX United States
  • FSI Canada
  • Employees
  • VNRX N/A
  • FSI N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • FSI Recreational Games/Products/Toys
  • Sector
  • VNRX Health Care
  • FSI Consumer Discretionary
  • Exchange
  • VNRX Nasdaq
  • FSI Nasdaq
  • Market Cap
  • VNRX 52.4M
  • FSI 55.6M
  • IPO Year
  • VNRX N/A
  • FSI 1999
  • Fundamental
  • Price
  • VNRX $0.50
  • FSI $4.41
  • Analyst Decision
  • VNRX Strong Buy
  • FSI
  • Analyst Count
  • VNRX 4
  • FSI 0
  • Target Price
  • VNRX $4.17
  • FSI N/A
  • AVG Volume (30 Days)
  • VNRX 263.7K
  • FSI 30.1K
  • Earning Date
  • VNRX 05-15-2025
  • FSI 05-15-2025
  • Dividend Yield
  • VNRX N/A
  • FSI 2.27%
  • EPS Growth
  • VNRX N/A
  • FSI N/A
  • EPS
  • VNRX N/A
  • FSI 0.18
  • Revenue
  • VNRX $1,308,361.00
  • FSI $36,483,680.00
  • Revenue This Year
  • VNRX $563.72
  • FSI $21.91
  • Revenue Next Year
  • VNRX $160.43
  • FSI $42.35
  • P/E Ratio
  • VNRX N/A
  • FSI $24.29
  • Revenue Growth
  • VNRX 64.16
  • FSI N/A
  • 52 Week Low
  • VNRX $0.40
  • FSI $1.65
  • 52 Week High
  • VNRX $0.90
  • FSI $7.24
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 52.42
  • FSI 54.39
  • Support Level
  • VNRX $0.40
  • FSI $4.22
  • Resistance Level
  • VNRX $0.54
  • FSI $4.63
  • Average True Range (ATR)
  • VNRX 0.05
  • FSI 0.35
  • MACD
  • VNRX 0.00
  • FSI 0.02
  • Stochastic Oscillator
  • VNRX 73.57
  • FSI 44.67

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: